Search research articles
Contact Us
Filters
Showing results (271-280 of 285) with videos related to
Page
of 29
Sort By:
Alimentary Pharmacology & Therapeutics
|
October 20, 2007
Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis
R Eliakim, Z Tulassay, L Kupcinskas, et al.
Kidney International
|
January 5, 2000
Inhibition of pressure natriuresis in mice lacking the AT2 receptor
V Gross, W H Schunck, H Honeck, et al.
Gut
|
June 9, 1998
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group
V Gross, T Andus, K W Ecker, et al.
The Journal of Biological Chemistry
|
May 16, 2000
Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor
C Schmitz, M Gotthardt, S Hinderlich, et al.
Molecular Psychiatry
|
January 23, 2002
Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder
R H Segman, A Meltzer, V Gross-Tsur, et al.
European Journal of Gastroenterology & Hepatology
|
September 1, 1996
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group
V Gross, T Andus, I Caesar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 9, 1999
Farnesol blocks the L-type Ca2+ channel by targeting the alpha 1C subunit
U C Luft, R Bychkov, M Gollasch, et al.
Endoscopy
|
November 24, 1998
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial
H Messmann, P Schaller, T Andus, et al.
Gastroenterology
|
January 29, 2000
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
H Lochs, M Mayer, W E Fleig, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Hypertension-induced end-organ damage : A new transgenic approach to an old problem
F C Luft, E Mervaala, D N Müller, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 285) with videos related to
Sort By:
Page
of 29
Alimentary Pharmacology & Therapeutics
|
October 20, 2007
Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis
R Eliakim, Z Tulassay, L Kupcinskas, et al.
Kidney International
|
January 5, 2000
Inhibition of pressure natriuresis in mice lacking the AT2 receptor
V Gross, W H Schunck, H Honeck, et al.
Gut
|
June 9, 1998
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group
V Gross, T Andus, K W Ecker, et al.
The Journal of Biological Chemistry
|
May 16, 2000
Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor
C Schmitz, M Gotthardt, S Hinderlich, et al.
Molecular Psychiatry
|
January 23, 2002
Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder
R H Segman, A Meltzer, V Gross-Tsur, et al.
European Journal of Gastroenterology & Hepatology
|
September 1, 1996
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group
V Gross, T Andus, I Caesar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 9, 1999
Farnesol blocks the L-type Ca2+ channel by targeting the alpha 1C subunit
U C Luft, R Bychkov, M Gollasch, et al.
Endoscopy
|
November 24, 1998
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial
H Messmann, P Schaller, T Andus, et al.
Gastroenterology
|
January 29, 2000
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
H Lochs, M Mayer, W E Fleig, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Hypertension-induced end-organ damage : A new transgenic approach to an old problem
F C Luft, E Mervaala, D N Müller, et al.
Page
of 29